Postmarket surveillance of natural health products in Canada: clinical and federal regulatory perspectives

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.85, Iss.9, 2007-09, pp. : 952-955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surveillance of Suspected Adverse Reactions to Natural Health Products: The Case of Propolis

By Menniti-Ippolito Francesca

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 419-423

Adis International

Access to resources Recommend Favorite

Selection of natural health products for clinical trials: a preclinical template

By Vohra S. Adams D. Hudson J.B. Moore J.A. Vimalanathan S. Sharma M. Burt A.J. Lamont E. Lacaze N. Arnason J.T. Lee T.D.G.

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 5, 2009-05 ,pp. : 371-378

NRC Research Press

Access to resources Recommend Favorite

Fluorinated Natural Products with Clinical Significance

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 14, 2006-07 ,pp. : 1529-1543

Bentham Science Publishers

Access to resources Recommend Favorite

Health Canada issues alerts for multiple products

Reactions Weekly, Vol. 1, Iss. 1269, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Health Canada warns against using foreign health products

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite